CORMEDIX INC. - COMMON
9.9800
27-November-24 15:45:00
15 minutes delayed
Stocks
+0.2000
+2.04%
Today's range
9.6100 - 10.2600
ISIN
N/A
Source
NASDAQ
-
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
26 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
04 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
30 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
24 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
23 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator
08 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces New Commercial Agreement
19 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
13 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces New Commercial Agreement
09 Sep 2024 09:52:30 By Nasdaq GlobeNewswire
-
14 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
07 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Outpatient Availability of DefenCath
03 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
18 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
06 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
10 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
06 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
19 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >